Position in EWTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$9,112,902
+$2,047,767 QoQ
Shares Held
224,290
0.0% QoQ
Ownership
0.207%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#54
of 223 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EWTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Woodline Partners LP holds $4,400,572,274 across 197 Biotechnology names. EWTX ranks #103 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,002,863 | $375,096,182 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
1,414,173 | $173,349,326 | |
| 3 | TNGX |
Tango Therapeutics, Inc.
|
4,000,567 | $125,057,724 | |
| 4 | BHVN |
Biohaven Ltd.
|
7,660,280 | $113,984,966 | |
| 5 | COGT |
Cogent Biosciences, Inc.
|
2,603,162 | $100,742,369 | |
| 6 | CYTK |
Cytokinetics Inc
|
1,100,708 | $93,769,314 | |
| 7 | RCUS |
Arcus Biosciences, Inc.
|
3,007,798 | $92,730,412 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
2,500,673 | $88,498,817 |
All Filings in EWTX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,112,902 | 224,290 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $7,065,135 | 224,290 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,563,324 | 224,192 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,636,361 | 224,190 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $14,379,873 | 1,096,863 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $24,129,798 | 1,096,809 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $15,144,720 | 567,218 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $14,088,022 | 527,839 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $7,593,088 | 421,604 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $7,389,607 | 405,132 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $4,422,079 | 404,212 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,063,332 | 360,093 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,790,720 | 360,093 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,401,820 | 360,093 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,219,213 | 360,091 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $5,312,261 | 539,864 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,143,504 | 771,797 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,492,902 | 360,093 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $6,155,532 | 402,849 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $6,006,228 | 361,821 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $7,561,250 | 354,489 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $11,616,442 | 357,429 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||